Casa
test vivo

In vivo tests - UB-CARE ITALY

Por um escritor misterioso

Descrição
In vivo tests - UB-CARE ITALY
In vitro safety - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
In vitro efficacy - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
In vivo tests - UB-CARE ITALY
Profiling ubiquitin signalling with UBIMAX reveals DNA damage- and SCFβ-Trcp1-dependent ubiquitylation of the actin-organizing protein Dbn1
In vivo tests - UB-CARE ITALY
Microglial debris is cleared by astrocytes via C4b-facilitated phagocytosis and degraded via RUBICON-dependent noncanonical autophagy in mice
In vivo tests - UB-CARE ITALY
who we are - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
Bioprinting: From Tissue and Organ Development to in Vitro Models
In vivo tests - UB-CARE ITALY
UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
In vivo tests - UB-CARE ITALY
IJMS, Free Full-Text
In vivo tests - UB-CARE ITALY
UB-CARE - Sperimentazioni in vitro, analisi, biosafety
In vivo tests - UB-CARE ITALY
Microbiology - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
In vitro testing as an alternative to in vivo biocompatibility
In vivo tests - UB-CARE ITALY
In vitro efficacy - UB-CARE ITALY
In vivo tests - UB-CARE ITALY
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
de por adulto (o preço varia de acordo com o tamanho do grupo)